The molecular basis of IgE antibody binding to thiopentone. Binding of IgE from thiopentone-allergic and non-allergic subjectsAnesthetic activity of novel water-soluble 2 beta-morpholinyl steroids and their modulatory effects at GABAA receptors.Stereochemistry in anaesthetic and analgetic drugs.Does the use of thiopental provide added cerebral protection during deep hypothermic circulatory arrest?Drugs as allergens: the molecular basis of IgE binding to thiopentone.Resistance of brain glucose metabolism to thiopental-induced CNS depression in newborn piglets.Placental transfer and pharmacokinetics of thiopentone in newborn infants.Effects of ketamine, propofol, or thiopental administration on intraocular pressure and qualities of induction of and recovery from anesthesia in horses.Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).The effects of the non-volatile anaesthetic agents, propofol and thiopental, on erythrocyte sedimentation rate.HPTLC method for the assay of thiopental in post-mortem blood in a fatal case of suicide.Propofol and thiopental as anesthetic agents in electroconvulsive therapy: a retrospective study in major depression.Propofol and thiopental suppress amyloid fibril formation and GM1 ganglioside expression through the γ-aminobutyric acid A receptor.Elementary Ca2+ release events in mammalian skeletal muscle: effects of the anaesthetic drug thiopental.A simplified high-pressure liquid chromatography method for determining lipophilicity for structure-activity relationships.Electroencephalographic effects of thiopentone and its enantiomers in the rat.Thiopentone and propofol: a compatible mixture?Predicting blood-brain barrier permeation from three-dimensional molecular structure.[CLINICAL CONSIDERATIONS ON THE USE OF LEPTONARCOSIS IN THE CESAREAN SECTION OPERATION][CONSIDERATIONS ON THE TECHNIC OF ANESTHESIA IN 300 CESAREAN SECTIONS PERFORMED IN THE PERIOD 1957-62.][TECHNIC OF ADMINISTRATION AND POSTOPERATIVE COURSE OF ULTRA SHORT-ACTING BARBITURATES IN CESAREAN SECTION.][ANESTHESIA IN CESAREAN SECTION WITH ULTRA SHORT-ACTING BARBITURATES AND THEIR ACTION ON UTERINE MUSCULAR FIBROCELLS, ON THE RESPIRATORY CENTER AND ON BLOOD COAGULATION][ANESTHESIA IN 232 CASES OF CESAREAN SECTION PERFORMED AT THE CASA SELLIEVA DELLA SOFFERENZA OF SAN GIOVANNI ROTONDO.][ON THE USE OF MIXED ANESTHESIA IN CESAREAN SECTION.][ANESTHESIA IN CESAREAN SECTION.][CONSIDERATIONS ON BARBITURIC ANESTHESIA IN THE COURSE OF CESAREAN SECTION.][NEONATAL MORTALITY IN REPEATED CESAREAN SECTION. (CONSIDERATIONS FROM THE ANESTHESIOLOGICAL POINT OF VIEW)][CONSIDERATIONS ON THE USE OF SPINAL ANESTHESIA AND OF LEPTONARCOSIS FOR THE ABDOMINAL CESAREAN SECTION][Decrease in the incidence of cesarean section in childbirth brought about by the introduction of the perfusion of oxytocics under general pentothal anesthesia.][CONSIDERATIONS ON ANESTHESIA IN CESAREAN SECTION.][DECREASE OF THE INCIDENCE OF CESAREAN SECTION DURING LABOR BY THE INTRODUCTION OF OXYTOCIC PERFUSION UNDER GENERAL ANESTHESIA WITH PENTOTHAL.][Our experience with general intravenous anesthesia in cesarean section.]Premedication with intranasal dexmedetomidine decreases barbiturate requirement in pediatric patients sedated for magnetic resonance imaging: a retrospective study
P921
Q28331460-038DD0F1-C817-482E-860B-5E57E2D47F02Q34427808-018917F8-DFC9-4854-96C8-409B2F571AA9Q36258833-70393012-24B0-4067-9772-1EC21488CCFFQ37024192-341889A8-AAE9-4850-9348-8E0795DD7C24Q42219561-23A0EE79-4A80-45C9-A664-84CF4A3BD571Q42519086-B11789B1-83EC-45DE-B3E3-D318A76B7EBEQ43057991-B91DE855-EC5F-4F5C-B310-C6F0862BD9F7Q43891407-0209314C-C0D6-4171-9DD1-ECF1263B1E1DQ46460075-A29A9B12-4AA2-4C80-87B8-554DBAF5B47CQ46592708-DD4033EB-E061-4013-9CD7-212901786D03Q48021927-D7BAAD23-F11A-4A72-ACE0-5DBA0A37C15FQ48027276-F0B0A10D-7386-40E7-B328-E78CE5FDC42BQ48089313-45C340D5-9047-40ED-AB0F-1A1C184C3F1AQ48673034-764ED58E-3E06-460C-BADE-C23611E49539Q48783857-A9E26293-F556-488E-BC47-C96635855364Q51419519-994BA0A7-9A0C-4481-8593-C5456DA26133Q51506110-6494CE5C-8C5D-4066-83CC-4318B05DABF9Q52077735-3DF902DE-D692-4976-AF24-E5E6D97A0344Q61843715-34E99B87-D7AA-416A-B732-F13343FAB88AQ61843886-8AEF2C79-B33E-4915-96A7-DADECA20D182Q61843892-B5767C20-2BE6-432C-BE8A-DB47F993093EQ61843899-166EFD35-0158-4CB4-BEE8-5252A9CACF16Q61843904-044DBFAE-ACC7-4EBF-AEC9-026BE34702C2Q61843921-FCF3B7CF-6EAA-404E-B307-AFC6290066D8Q61844019-BB365F9F-7293-4B64-91E1-09CE09D475B1Q61844107-C966962A-0094-4FF5-955A-C2D67427A726Q61844112-71DEFFA7-2B24-443B-97A8-7F3646E0CB2EQ61844128-39E6E40B-D74C-4BD7-8153-5551E6586482Q61844234-16296F6F-7912-48C3-939E-3B95FFA0F0C8Q61844251-1674C7A8-F763-42A6-8769-80D52B31D58CQ61844388-2C1AD881-4867-4D4F-B007-3547DAC70ABCQ61844477-A16DBF2E-6D67-4A9E-BBE8-D483A076AD71Q64242332-A9815EF7-D608-4DCA-B819-92116E3CF9F3
P921
description
Schlafmittel
@de
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Pentotal
@tr
Thiopental
@de
Tiopentaali
@fi
Tiopental
@ca
Tiopental
@nb
Tiopental
@pl
Tiopental
@pt
Tiopental
@sv
Tiopentalo
@eo
thiopental
@en
type
label
Pentotal
@tr
Thiopental
@de
Tiopentaali
@fi
Tiopental
@ca
Tiopental
@nb
Tiopental
@pl
Tiopental
@pt
Tiopental
@sv
Tiopentalo
@eo
thiopental
@en
altLabel
(+-)-Thiopental
@en
2-Thio-5-ethyl-5-sec-pentylbarbituric acid
@en
5-Ethyl-5-(1-methyl-butyl)-2-thioxo-dihydro-pyrimidine-4,6-dione
@en
Bitaryl
@en
Omexolon
@en
Penthiobarbital
@en
Pentothiobarbital
@en
Sodium Pentothal
@en
Thiomebumalum
@en
Thiopental
@en
prefLabel
Pentotal
@tr
Thiopental
@de
Tiopentaali
@fi
Tiopental
@ca
Tiopental
@nb
Tiopental
@pl
Tiopental
@pt
Tiopental
@sv
Tiopentalo
@eo
thiopental
@en
P4964
P527
P6689
P592
P661
P662
P665
P683
P1296
P1579
P2115
N0000148030
P231
P232
P234
1S/C11H18N2O2S/c1-4-6-7(3)11(5 ...... -6H2,1-3H3,(H2,12,13,14,15,16)
P235
IUJDSEJGGMCXSG-UHFFFAOYSA-N
P2566
100.000.896